Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel

Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel

Heterozygous familial hypercholesterolaemia (FH) is among the most common genetic metabolic lipid disorders characterised by elevated low-density lipoprotein cholesterol (LDL-C) levels from birth and a significantly higher risk of developing premature atherosclerotic cardiovascular disease. The majo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bojko Bjelakovic, Claudia Stefanutti, Željko Reiner, Gerald F. Watts, Patrick Moriarty, David Marais, Kurt Widhalm, Hofit Cohen, Mariko Harada-Shiba, Maciej Banach
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
familial hypercholesterolaemia
children
cardiovascular risk
vascular phenotype
Medicine
R
Acceso en línea:https://doaj.org/article/a550713b086740e59606f49fcc9b6b6f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares